Siena, S., Raghav, K., Masuishi, T., Yamaguchi, K., Nishina, T., Elez, E., Rodriguez, J., Chau, I., Bartolomeo, M. D., Kawakami, H., Suto, F., Koga, M., Inaki, K., Kuwahara, Y., Takehara, I., Barrios, D., Kobayashi, K., Grothey, A., Yoshino, T. (2025). Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01. Nature Communications. https://doi.org/10.1038/s41467-025-56170-9